利索-全球专利检索

  1. 登录
  2. 注册
发明授权
US07576085B2 Imidazopyrazines as cyclin dependent kinase inhibitors 失效
咪唑吡嗪作为细胞周期蛋白依赖性激酶抑制剂

Imidazopyrazines as cyclin dependent kinase inhibitors
摘要：
In its many embodiments, the present invention provides a novel class of imidazo[1,2-a]pyrazine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions. An illustrative compound of the invention is shown below:
摘要（中）：

在其许多实施方案中，本发明提供了一类新颖的咪唑并[1,2-a]吡嗪化合物作为细胞周期蛋白依赖性激酶的抑制剂，制备此类化合物的方法，含有一种或多种此类化合物的药物组合物，制备药物制剂的方法 包括一种或多种这样的化合物，以及使用这些化合物或药物组合物治疗，预防，抑制或改善与CDK相关的一种或多种疾病的方法。 本发明的说明性化合物如下所示：

公开/授权文献
信息查询
Espacenet
0/0